Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-011693

Options or other derivatives

  • Director acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CAIN CHRISTOPHER W. Director 2021-03-11 Grant or award · Stock Option (Right to Buy) +60,000 60,000 D
Loading xslF345X03/doc4.xml…